Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong · Delayed Price · Currency is HKD 38.50
+1.12 (3.00%)
Aug 21, 2026, 4:08 PM HKT
Sunshine Lake Pharma Revenue
In the year 2025, Sunshine Lake Pharma had annual revenue of 4.82B CNY with 19.81% growth. Sunshine Lake Pharma had revenue of 2.88B in the half year ending December 31, 2025, a decrease of -6.75%.
Revenue
4.82B CNY
Revenue Growth
+19.81%
P/S Ratio
4.13
Revenue / Employee
757.92K CNY
Employees
6,353
Market Cap
22.15B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.82B | 796.16M | 19.81% |
| Dec 31, 2024 | 4.02B | -2.28B | -36.15% |
| Dec 31, 2023 | 6.29B | 2.55B | 68.08% |
| Dec 31, 2022 | 3.74B | 2.83B | 309.83% |
| Dec 31, 2021 | 913.79M | -1.43B | -61.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Resources Pharmaceutical Group | 299.99B |
| The United Laboratories International Holdings | 14.70B |
| Grand Pharmaceutical Group | 12.28B |
| Simcere Pharmaceutical Group | 10.07B |
| China Medical System Holdings | 10.06B |
| Shandong Xinhua Pharmaceutical Company | 9.94B |
| Luye Pharma Group | 7.02B |
| Consun Pharmaceutical Group | 3.80B |
Sunshine Lake Pharma News
- 5 months ago - Sunshine Lake Pharma Earnings release: H2 2025 - Filings
- 5 months ago - Sunshine Lake Pharma Annual report: H2 2025 - Filings
- 1 year ago - Sunshine Lake Pharma Quarterly report: H1 2025 - Filings
- 1 year ago - Sunshine Lake Pharma Earnings release: H1 2025 - Filings